E-LIB Suche - Ergebnisse für: van Bodegraven, A. A.

1

P594 One-year success rates of targeted therapy in Ulcerati..:

Creemers, R ; van Andel, E ; Wintjens, D.
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1156-i1157 , 2024

Link: https://doi.org/10.1093/..

2

P1078 The influence of different 5-aminosalicylic acid prep..:

Anjie, S ; Hettinga, J ; Volkers, A G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1939-i1940 , 2024

Link: https://doi.org/10.1093/..

3

P189 Lifestyle and psychosocial factors in IBD; prevalence ..:

Demers, K ; Hendrix, E M B ; Rezazadeh Ardabili, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i500-i502 , 2024

Link: https://doi.org/10.1093/..

4

P909 Proactive therapeutic drug monitoring and pharmacogeno..:

Anjie, S ; Derijks, L J ; Volkers, A G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1662-i1663 , 2024

Link: https://doi.org/10.1093/..

5

P526 A prediction model for successful increase of adalimum..:

Van Linschoten, R ; Jansen, F ; Pauwels, R...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i655-i657 , 2023

Link: https://doi.org/10.1093/..

6

P503 The risk of mild, moderate and severe infections in IB..:

Rezazadeh Ardabili, A ; van Esser, D ; Wintjens, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i631-i634 , 2023

Link: https://doi.org/10.1093/..

7

Abdominal pain in patients with inflammatory bowel disease ..:

Janssen, L. M. ; Rezazadeh Ardabili, A. ; Romberg‐Camps, M. J. L....
Alimentary Pharmacology & Therapeutics. 58 (2023) 10 - p. 1041-1051 , 2023

Link: https://doi.org/10.1111/..

8

P211 Factors associated with estimated cardiorespiratory fi..:

Demers, K ; Rezazadeh Ardabili, A ; Bongers, B C...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i362-i364 , 2023

Link: https://doi.org/10.1093/..

9

P464 Rac1/pSTAT3 expression in T lymphocytes: A potential p..:

Deben, D ; Creemers, R ; Van Adrichem, A...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i438-i439 , 2022

Link: https://doi.org/10.1093/..

10

P714 Comparison of intestinal microbiota profiles of faecal..:

Van Rossen, T ; van den Hoek, K ; Budding, A.
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i609-i610 , 2022

Link: https://doi.org/10.1093/..

11

P11-25 Unraveling the molecular mechanisms of capecitabine-..:

Rodrigues, D. ; van Kampen, R. ; van Bodegraven, A....
Toxicology Letters. 368 (2022) - p. S172 , 2022

Link: https://doi.org/10.1016/..

12

DOP75 Effectiveness and Safety of tofacitinib versus vedoli..:

Straatmijer, T ; Visschedijk, M ; de Vries, A...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i118-i120 , 2022

Link: https://doi.org/10.1093/..

13

P650 IBD care from the patient perspective: The patient's t..:

Creemers, R ; van der Horst, D ; Raats, I...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i565-i565 , 2022

Link: https://doi.org/10.1093/..

14

P595 Validation of a predictive algorithm for thiopurine in..:

Van Moorsel, F ; Deben, D ; Creemers, R...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i530-i531 , 2022

Link: https://doi.org/10.1093/..

15

P183 A systematic review on outcome measures of long-term e..:

Janssen, L ; Creemers, R ; van Bodegraven, A.
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i248-i249 , 2022

Link: https://doi.org/10.1093/..